Total: 27748 results found.
Page 1307 of 1388
The FINANCIAL -- Just over half of the NUTS regions of the European Union (EU) recorded a decrease of at least 0.5 percentage points5 in their regional unemployment rate3 in 2014 compared with 2013.
The FINANCIAL -- The nation’s leading housing economists spoke on April 21 at an economic and policy forum to appraise the state of the U.S. housing market. The event, held by the National Association of Realtors, National Association of Home Builders, and McGraw Hill Financial Global Institute, drew more than 80 attendees representing industry analysts, congressional staff, and members of the media.
The FINANCIAL -- Last year the Rock and Roll Hall of Fame inducted the songwriter who rhetorically asked, “Where Do the Children Play?” This year, the artist formerly known as Cat Stevens got his answer in a report from RealtyTrac, the nation’s one of the leading sources for comprehensive housing data.
The FINANCIAL -- Freddie Mac on April 21 announced its first Extended Timeline Pool Offering (EXPO), an auction of deeply delinquent non-performing loans (NPLs) from its mortgage investment portfolio.
The FINANCIAL -- Swiss Re's shareholders approved all proposals put forward by the Board of Directors at its Annual General Meeting held in Zurich on April 21.
The FINANCIAL -- Allianz achieved solid results in Latin America in 2014 despite a more modest growth environment. Total revenues amounted to 2.44 billion euros (2013: 2.68 billion euros).
The FINANCIAL -- In a challenging environment, Allianz in Central and Eastern Europe (CEE)1 reported solid results for 2014.
The FINANCIAL -- Allianz continued its successful course in Asia-Pacific and achieved another strong end-of-year result for 2014. Total revenue was reported at 7.9 billion euros compared with 7.2 billion euros in the previous year, an increase of 9 percent.
The FINANCIAL -- EnterNext, the Euronext subsidiary dedicated to promoting and growing the market for SMEs on April 21 congratulated Sensorion, a biotech company specialising in the treatment of pathologies of the inner ear, on its successful listing on Alternext in Paris.
The FINANCIAL -- Amgen on April 21 announced financial results for the first quarter of 2015. Key results include:
The FINANCIAL -- Pfizer Inc. announced on April 21 that XALKORI (crizotinib) received Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for the potential treatment of patients with ROS1-positive non-small cell lung cancer (NSCLC).
The FINANCIAL -- Commenting on the Group’s results, Roche CEO Severin Schwan said: “We started the year with strong growth and good uptake of new products. In particular, I am pleased to see continued strong demand for Perjeta for breast cancer, as well as Esbriet, which was recently approved in the US for idiopathic pulmonary fibrosis. During the first quarter, the FDA also granted a second Breakthrough Therapy Designation for our cancer immunotherapy medicine anti-PDL1, for a specific type of lung cancer, in addition to bladder cancer. In Diagnostics, we further broadened the menu for the recently launched cobas 6800/8800 instrument platform. Overall, we are on track to reach our full-year targets for 2015.”
The FINANCIAL -- Teva Pharmaceutical Industries Ltd. on April 21 announced a proposal to acquire all of the outstanding shares of Mylan N.V. (NASDAQ: MYL) in a transaction valued at $82.00 per Mylan share, with the consideration to be comprised of approximately 50 percent cash and 50 percent stock.
The FINANCIAL -- Astellas Pharma Inc. and Potenza Therapeutics, Inc., a biotechnology company developing a portfolio of immuno-oncology programs, on April 22 announced an exclusive research and development collaboration.
The FINANCIAL -- New findings from an international survey of people living with multiple sclerosis (MS) and neurologists show that multiple factors in the patient-physician dynamic contribute to overall patient treatment satisfaction, including patients’ treatment expectations, degree of input into the treatment decision-making process and communication with their physicians.
The FINANCIAL -- Providing effective treatment for those with cannabis use disorders is likely to become a matter of growing importance in European drug policy. This is according to the EU drugs agency (EMCDDA) today as it launches a new in-depth study: Treatment of cannabis-related disorders in Europe.
The FINANCIAL -- Abbott on April 22 announced financial results for the first quarter ended March 31, 2015.
The FINANCIAL -- The EU on April 21 disbursed a loan of €250 million to Ukraine, the last disbursement under the first Macro-Financial Assistance (MFA) operation for Ukraine, which amounts to a total of €610 million, according to EU Neighbourhood Info Centre.
The FINANCIAL -- Moldova and Ukraine have successfully identified key needs for assisting both countries to fulfil the customs obligations of their Association Agreement and related Deep and Comprehensive Free Trade Area (AA/DCFTA) with the EU, in cooperation with the EU Border Assistance Mission to Moldova and Ukraine (EUBAM).
The FINANCIAL -- The USA is ready to give Ukraine some loan guarantees at the sum of 1 bln USD in 2015, told Joseph Biden, Vice President of the United States, during a telephone conversation with Petro Poroshenko, President of Ukraine, informed the press-service of the White House on April 21, according to APK Inform-Agency.